UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Enzon Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
293904108
(CUSIP Number)
May 18, 2006
(Date of event which requires filing of this statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
----------------
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 17 Pages
CUSIP No. 293904108 13G Page 2 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Highbridge International LLC
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands, British West Indies
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON **
OO
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 3 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Highbridge Capital Corporation
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands, British West Indies
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9 AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
________________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
OO
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 4 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Highbridge Capital L.P.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES ________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON **
PN
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 5 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Highbridge Master L.P.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands, British West Indies
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON **
PN
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 6 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Highbridge GP, Ltd.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands, British West Indies
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
________________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
OO
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 7 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Highbridge GP, LLC
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
________________________________________________________________________________
(12) TYPE OF REPORTING PERSON **
OO
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 8 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Highbridge Capital Management, LLC 20-1901985
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON **
OO - Limited Liability Company
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 9 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Glenn Dubin
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON **
IN
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 10 of 17 Pages
--------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Henry Swieca
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP **
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES _________________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
OWNED BY _________________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING _________________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
4.0% Convertible Senior Notes, due 2013, convertible into
3,455,496 shares of Common Stock
235,656 shares of Common Stock
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES **
[ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
7.8%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON **
IN
--------------------------------------------------------------------------------
** SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 293904108 13G Page 11 of 17 Pages
Item 1.
(a) Name of Issuer
Enzon Pharmaceuticals, Inc. (the "Company").
(b) Address of Issuer's Principal Executive Offices
685 Route 202/206
Bridgewater, New Jersey 08807
Item 2(a). Name of Person Filing
Item 2(b). Address of Principal Business Office
Item 2(c). Citizenship
HIGHBRIDGE INTERNATIONAL LLC
c/o Harmonic Fund Services
The Cayman Corporate Centre, 4th Floor
27 Hospital Road
Grand Cayman, Cayman Islands, British West Indies
Citizenship: Cayman Islands, British West Indies
HIGHBRIDGE CAPITAL CORPORATION
c/o Harmonic Fund Services
The Cayman Corporate Centre, 4th Floor
27 Hospital Road
Grand Cayman, Cayman Islands, British West Indies
Citizenship: Cayman Islands, British West Indies
HIGHBRIDGE MASTER L.P.
c/o Harmonic Fund Services
The Cayman Corporate Centre, 4th Floor
27 Hospital Road
Grand Cayman, Cayman Islands, British West Indies
Citizenship: Cayman Islands, British West Indies
HIGHBRIDGE CAPITAL L.P.
c/o Highbridge Capital Management, LLC
9 West 57th Street, 27th Floor
New York, New York 10019
Citizenship: State of Delaware
HIGHBRIDGE GP, LTD.
c/o Harmonic Fund Services
The Cayman Corporate Centre, 4th Floor
27 Hospital Road
Grand Cayman, Cayman Islands, British West Indies
Citizenship: Cayman Islands, British West Indies
HIGHBRIDGE GP, LLC
c/o Highbridge Capital Management, LLC
9 West 57th Street, 27th Floor
New York, New York 10019
Citizenship: State of Delaware
HIGHBRIDGE CAPITAL MANAGEMENT, LLC IRS #: 20-1901985
CUSIP No. 293904108 13G Page 12 of 17 Pages
9 West 57th Street,
27th Floor
New York, New York 10019
Citizenship: State of Delaware
GLENN DUBIN
c/o Highbridge Capital Management, LLC
9 West 57th Street, 27th Floor
New York, New York 10019
Citizenship: United States
HENRY SWIECA
c/o Highbridge Capital Management, LLC
9 West 57th Street, 27th Floor
New York, New York 10019
Citizenship: United States
Item 2(d) Title of Class of Securities
Common Stock, $0.01 par value ("Common Stock")
Item 2(e) CUSIP Number
293904108
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or
(c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
(b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15
U.S.C. 78c).
(d) [ ] Investment company registered under Section 8 of the Investment
Company Act of 1940 (15 U.S.C. 80a-8).
(e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with Rule
13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with Rule
13d-1(b)(1)(ii)(G);
(h) [ ] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an investment
company under Section 3(c)(14) of the Investment Company Act of 1940 (15
U.S.C. 80a-3);
(j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box. [X]
CUSIP No. 293904108 13G Page 13 of 17 Pages
Item 4. Ownership
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
As of the date of this filing, each Reporting Person may be
deemed the beneficial owner of (i) 4.0% Convertible Senior Notes due 2013
convertible into 3,455,496 shares of Common Stock issuable to Highbridge
International LLC and (ii) 235,656 shares of stock issued to Highbridge
International LLC.
Highbridge International LLC is a subsidiary of Highbridge
Master L.P. Highbridge Capital Corporation and Highbridge Capital L.P. are
limited partners of Highbridge Master L.P. Highbridge GP, Ltd. is the General
Partner of Highbridge Master L.P. Highbridge GP, LLC is the General Partner of
Highbridge Capital L.P. Highbridge Capital Management, LLC is the trading
manager of Highbridge Capital Corporation, Highbridge Capital L.P. and
Highbridge Master L.P. Glenn Dubin is a Co-Chief Executive Officer of Highbridge
Capital Management, LLC. Henry Swieca is a Co-Chief Executive Officer of
Highbridge Capital Management, LLC. The foregoing should not be construed in and
of itself as an admission by any Reporting Person as to beneficial ownership of
shares of Common Stock owned by another Reporting Person. In addition, each of
Highbridge Master L.P., Highbridge Capital Corporation, Highbridge Capital L.P.,
Highbridge GP, Ltd., Highbridge GP, LLC, Highbridge Capital Management, LLC,
Glenn Dubin and Henry Swieca disclaims beneficial ownership of shares of Common
Stock owned by Highbridge International LLC.
(b) Percent of class:
The Company's quarterly report on Form 10-Q that was filed on
May 3, 2006, indicates there were 43,761,855 shares of Common Stock outstanding
as of May 1, 2006. Therefore, based on the Company's outstanding shares of
Common Stock and the Common Stock issuable upon the conversion of the 4.0%
Convertible Senior Notes due 2013, issued by the Company, the Reporting Persons
may be deemed to beneficially own approximately 7.8% of the outstanding shares
of Common Stock of the Company. The foregoing should not be construed in and of
itself as an admission by any Reporting Person as to beneficial ownership of
shares of Common Stock owned by another Reporting Person.
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote
0
(ii) Shared power to vote or to direct the vote
See Item 4(a)
(iii) Sole power to dispose or to direct the disposition of
0
CUSIP No. 293904108 13G Page 14 of 17 Pages
(iv) Shared power to dispose or to direct the disposition of
See Item 4(a)
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company or Control
Person
Not applicable.
Item 8. Identification and Classification of Members of the Group
See Exhibit I.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below each of the undersigned certifies that, to the best of
its knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that
purpose or effect.
Exhibits:
Exhibit I: Joint Filing Agreement, dated as of May 26, 2006, by and among
Highbridge International LLC, Highbridge Capital Corporation, Highbridge Capital
L.P., Highbridge Master L.P., Highbridge GP, Ltd., Highbridge GP, LLC,
Highbridge Capital Management, LLC, Glenn Dubin and Henry Swieca.
CUSIP No. 293904108 13G Page 15 of 17 Pages
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief,
each of the undersigned certifies that the information with respect to it set
forth in this statement is true, complete, and correct.
Dated: May 26, 2006
HIGHBRIDGE INTERNATIONAL LLC HIGHBRIDGE CAPITAL L.P.
By: Highbridge GP, LLC
By: /s/ Howard Feitelberg its General Partner
--------------------------
Name: Howard Feitelberg
Title: Director
By: /s/ Clive Harris
--------------------------
Name: Clive Harris
Title: Director
HIGHBRIDGE CAPITAL CORPORATION HIGHBRIDGE GP, LTD.
By: /s/ Clive Harris
--------------------------
Name: Clive Harris
Title: Director By: /s/ Clive Harris
--------------------------
Name: Clive Harris
Title: Director
HIGHBRIDGE MASTER L.P. HIGHBRIDGE CAPITAL MANAGEMENT, LLC
By: Highbridge GP, Ltd.
its General Partner
By: /s/ Carolyn Rubin
--------------------------
Name: Carolyn Rubin
Title: Deputy General Counsel
By: /s/ Clive Harris
--------------------------
Name: Clive Harris
Title: Director
HIGHBRIDGE GP, LLC
By: /s/ Clive Harris /s/ Henry Swieca
-------------------------- --------------------------
Name: Clive Harris
Title: Director HENRY SWIECA
/s/ Glenn Dubin
--------------------------
GLENN DUBIN
CUSIP No. 293904108 13G Page 16 of 17 Pages
EXHIBIT I
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the Schedule
13G filed with the Securities and Exchange Commission on or about the date
hereof with respect to the beneficial ownership by the undersigned of the Common
Stock, $0.01 par value, of Enzon Pharmaceuticals, Inc., is being filed, and all
amendments thereto will be filed, on behalf of each of the persons and entities
named below in accordance with Rule 13d-1(k) under the Securities Exchange Act
of 1934, as amended. This Agreement may be executed in two or more counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.
Dated as of May 26, 2006
HIGHBRIDGE INTERNATIONAL LLC HIGHBRIDGE CAPITAL L.P.
By: Highbridge GP, LLC
By: /s/ Howard Feitelberg its General Partner
--------------------------
Name: Howard Feitelberg
Title: Director
By: /s/ Clive Harris
--------------------------
Name: Clive Harris
Title: Director
HIGHBRIDGE CAPITAL CORPORATION HIGHBRIDGE GP, LTD.
By: /s/ Clive Harris
--------------------------
Name: Clive Harris
Title: Director By: /s/ Clive Harris
--------------------------
Name: Clive Harris
Title: Director
HIGHBRIDGE MASTER L.P. HIGHBRIDGE CAPITAL MANAGEMENT, LLC
By: Highbridge GP, Ltd.
its General Partner
By: /s/ Carolyn Rubin
--------------------------
Name: Carolyn Rubin
Title: Deputy General Counsel
By: /s/ Clive Harris
--------------------------
Name: Clive Harris
Title: Director
HIGHBRIDGE GP, LLC
By: /s/ Clive Harris /s/ Henry Swieca
-------------------------- --------------------------
Name: Clive Harris
Title: Director HENRY SWIECA
CUSIP No. 293904108 13G Page 17 of 17 Pages
/s/ Glenn Dubin
--------------------------
GLENN DUBIN